Robert Goodenow

Nessuna posizione attualmente

74 anni

Health Technology

Consumer Services

Profilo

Robert S.
Goodenow held several positions in the pharmaceutical industry, including Principal at Baxter International, Head-Oncology Business Development at Aventis, Secretary & Chief Business Officer at Syndax Pharmaceuticals, and Chief Business Officer at HUYA Bioscience International LLC.
He also served as Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. from 2002 to 2007.
Goodenow received a doctorate from Stanford University and an undergraduate degree from the University of California, Berkeley.

Precedenti posizioni note di Robert Goodenow

Società	Posizione	Fine
INOVIO PHARMACEUTICALS, INC.	Corporate Officer/Principal	16/03/2007
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Presidente	-
BAXTER INTERNATIONAL INC.	Corporate Officer/Principal	-
Aventis, Inc.	Corporate Officer/Principal	-
SYNDAX PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Robert Goodenow

Formazione di Robert Goodenow

University of California, Berkeley	Undergraduate Degree
Stanford University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robert Goodenow

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
INOVIO PHARMACEUTICALS, INC.	Health Technology
SYNDAX PHARMACEUTICALS, INC.	Health Technology
BAXTER INTERNATIONAL INC.	Health Technology

Aziende private	2
Aventis, Inc.
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Health Technology